Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin's Lymphoma
- the ECHELON-1 Study Group
- Mayo Clinic Rochester, MN
- University of Manchester
- Provincial Health Services Authority
- Maria Sklodowska-Curie Institute of Oncology
- Sungkyunkwan University
- Centre Antoine Lacassagne
- The University of Tennessee Graduate School of Medicine
- University of Rochester
- Stanford University
- University of Copenhagen
- Rutgers - The State University of New Jersey, New Brunswick
- Medical University of Łódź
- Washington University St. Louis
- National Cancer Center Korea
- Massachusetts General Hospital
- Takeda Development Center Americas
- Seagen Inc.
- Memorial Sloan-Kettering Cancer Center
Research output: Contribution to journal › Article › peer-review
276
Link opens in a new tab
Scopus
citations